Ionis Pharma's Bad Week Gets Worse

Ionis Pharmaceuticals Inc IONS shares are trading lower by $4.40 (8.7 percent) at $41.40 in Friday's session. The stock, which ended last week at $54.70, is now trading in the lower $40.00 handle.

The rout began Monday when a trial for Volanesorsen had mixed results. Although the study did meet its primary endpoint, five patients in the study had to discontinue due to injections site reactions.

That news instigated a $4.52 decline on Monday ($54.70 to $50.18), which was followed by a $3.67 decline on Tuesday. After a modest gain Wednesday and modest decline Thursday, a Goldman Sachs downgrade from Neutral to Sell has inflicted more misery on the investors long the issue.

After a much lower open, Ionis stock managed a brief rally to $43.00 before continuing its descent lower. So far, the ensuing decline has taken it to $40.76 and is attempting to rebound.

If the decline continues, there may be additional support at the pair of lows from January 30 ($40.47) and January 31 ($40.61).

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: TechnicalsIntraday UpdateMoversTrading Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!